Download presentation
Presentation is loading. Please wait.
Published byBarbara Alexander Modified over 6 years ago
1
“2nd World Congress on Rare Diseases and Orphan Drugs”
Management of Rare Diseases: An Integrated Approach to Break Down Barriers and Facilitate Patient Access to Healthcare “2nd World Congress on Rare Diseases and Orphan Drugs” Date: 29th and 30th June, 2017
2
“I am Dr. Gayathri Balasubramanian, a part of focus scientific research center, the scientific arm of phamax, which is a healthcare market access company. The views presented here are from secondary desk research and various initiatives undertaken by phamax at a global level.” Disclosure
3
Rare diseases – A snapshot
350 M 80% 50% 35%
4
Now a global issue Developed Countries Developing Countries
More than 6,000 rare diseases Rare disease affects < 1/500,000 More than 7,000 rare diseases Affects ~30 M European Union citizens Neonatal morbidity of < 1/10,000 Rare disease affects < 0.1% of the population ~ 70 M Indians are affected
5
Unaffordability Untreated cases Underdiagnoses Undefined process
Unavailing research Unawareness Unavailing research Undefined process Underdiagnoses Untreated cases Unaffordability Unawareness
6
Stakeholders’ Network
Journey so far Initiatives Plans and Policies Data/Registry Access Programs Cost of Care Centers of Excellence Stakeholders’ Network Comprehensive - Care
7
Recommendations Process Collaboration Awareness Regulations Guidelines
Policy Makers/Regulatory Bodies Healthcare Providers Process Collaboration Awareness Regulations Guidelines Policies Continued education Training Clinical guidelines Centers of excellence Comprehensive care Industry Partners/Researchers Patients/Patient Organization Continued research Drug development Mixed-methods research Awareness Advocacy Pathway establishment
8
Integrated Approach Drivers and Barriers Technology Novel Research
Stakeholders
9
Implementation Engage Develop Build Generate Collaborate Identify
Disseminate Facilitate
10
Lessons learnt from our experience
Tackling hepatitis in Africa – A Case study REACH Problem 01 Objective 02 Epidemiology Awareness Collaboration Health access Research Continued Approach 03 Outcomes 04
11
Global network of ~2,000 stakeholders of health; both international and local experts Network Composition: Physicians: 68% Policy: 23% Patient bodies: 9%
12
Thank you
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.